Preferred Treatment for Patients with Metastatic Melanoma

Categories: Cancer

?For more than 20 years, Interleukin-2 (IL2) was the preferred treatment for medically fit metastatic melanoma patients, but recently two new agents were approved for stage IV disease.?
Clickhere? to read the journal article.

?